January 10, 2024

Concord, CA – Prowess is proud to announce that it has received official registration approval from Colombia’s Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA). This significant achievement marks a milestone in the company’s commitment to providing high-quality products to the international market.

The registration, valid for a period of ten (10) years, allows the distribution and commercialization of Panther TPS in Colombia. The product has undergone a comprehensive verification process by INVIMA, ensuring compliance with national health and safety regulations.

“We are honored to receive this certification, which reinforces our dedication to delivering safe and effective products/services to customers in Colombia,” said Rick Smith, Director of Sales and Marketing. “This milestone opens up new opportunities for us to expand our presence in Latin America and continue offering solutions that meet the highest standards.”

Prowess looks forward to serving the Colombian market and contributing to the advancement of radiation oncology solutions in the region.

For more information or to schedule a product demonstration, please visit www.prowess.com or contact our support team at (925) 356-0360.